| Organisms (n = 296) | %Susa | Tigecycline MIC (μg/mL) |
||
|---|---|---|---|---|
| MIC50 | MIC90 | Range | ||
| Acinetobacter spp. (n = 161) | IE | 0.25 | 1 | 0.03–4 |
| P. aeruginosa (n = 208) | 8 | 16 | 0.5–>1 | 6 |
| Enterobacter spp. (n = 324) | 91.0 | 0.6 | 1 | 0.06–8 |
| Enterococcus spp. (n = 227) | 100 | 0.06 | 0.12 | 0.015–0.25 |
| VREs (n = 20) | 100 | 0.06 | 0.12 | 0.015–0.12 |
| E. coli (n = 531) | 99.8 | 0.12 | 0.25 | 0.03–2 |
| Klebsiella spp. (n = 413) | 91.0 | 0.6 | 1 | 0.12–8 |
| ESBLs (n = 71) | 85.9 | 0.6 | 2 | 0.06–8 |
| Serratia spp. (n = 118) | 91.5 | 0.5 | 1 | 0.12–8 |
| H. influenzae (n = 19) | IE | 0.12 | 0.25 | 0.03–0.5 |
| S. aureus (n = 282) | 100 | 0.12 | 0.25 | 0.03–0.5 |
| MRSA (n = 75) | 100 | 0.12 | 0.25 | 0.03–0.5 |
| S. agalactiae (n = 72) | 100 | 0.03 | 0.12 | 0.015–0.25 |
| S. pneumoniae (n = 182) | IE | 0.03 | 0.5 | ≤0.008–0.5 |
IE: Insufficient Evidence that this species is a good target for therapy with this drug.
a
–– indicates this species is a poor target for therapy with this drug.